In his last editor's desk, Reece Armstrong reflects on his time at the helm of European Pharmaceutical Manufacturer.
For a long time now, European Pharmaceutical Manufacturer’s content has been influenced by the Covid-19 pandemic. That I’ve worked on this title at such a time has been remarkable. Seeing the response of the life sciences industry was nothing short of inspiring and despite the challenges, the tragic death toll and restrictions on living, the industry’s actions compounded the fact that this is a sector which ultimately wants to do good.
The pharma industry had to adapt to the challenges of Covid-19 much like the rest of us and this has been reflected in developments across the sector’s entire supply chain. We’ve seen remote working start to become a core component in clinical trials, logistics suppliers work out the best ways to transport crucial therapies and vaccines, and regulators find ways to expedite approvals so people would have some form of protection against the virus.